companydata.dkBKG-PHARMA ApS: Financial statements 2012
CVR: 27959350
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 836,978 and a net result of DKK 535,020. Equity amounted to DKK 13,756,552. The solvency ratio was 90.8%.
- Gross Profit
- 836,978 kr.
- Profit/Loss
- 535,020 kr.
- Equity
- 13,756,552 kr.
- Total Assets
- 15,146,246 kr.
How creditworthy is BKG-PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of May 31, 2012, Frank Knudsen has left the board of directors of BKG-PHARMA ApS.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004 and dissolved in 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees. In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity amounted to DKK -2,682,678.